Literature DB >> 27736781

Coxiella burnetii Avirulent Nine Mile Phase II Induces Caspase-1-Dependent Pyroptosis in Murine Peritoneal B1a B Cells.

Laura Schoenlaub1, Rama Cherla1, Yan Zhang1, Guoquan Zhang2.   

Abstract

Our recent study demonstrated that virulent Coxiella burnetii Nine Mile phase I (NMI) is capable of infecting and replicating within peritoneal B1a cells and that B1a cells play an important role in host defense against C. burnetii infection in mice. However, it remains unknown if avirulent Nine Mile phase II (NMII) can infect and replicate in B1a cells and whether NMI and NMII can differentially interact with B1a cells. In this study, we examined if NMI and NMII can differentially modulate host cell apoptotic signaling in B1a cells. The results showed that NMII induced dose-dependent cell death in murine peritoneal B1a cells but NMI did not, suggesting that NMI and NMII may differentially activate host cell apoptotic signaling in B1a cells. Western blotting indicated that NMII-induced B1a cell death was not dependent on either caspase-3 or PARP-1 cleavage, but cleavage of caspase-1 was detected in NMII-infected B1a cells. In addition, inhibition or deficiency of caspase-1 activity blocked NMII-induced B1a cell death. These results suggest that NMII induces a caspase-1-dependent pyroptosis in murine peritoneal B1a cells. We also found that heat-killed NMII and type 4 secretion system (T4SS) mutant NMII were unable to induce B1a cell death and that NMII infection did not induce cell death in peritoneal B1a cells from Toll-like receptor 2 (TLR-2)- or NLRP3 inflammasome-deficient mice. These data suggest that NMII-induced caspase-1-dependent pyroptosis may require its T4SS and activation of the TLR-2 and NLRP3 signaling pathways.
Copyright © 2016, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27736781      PMCID: PMC5116740          DOI: 10.1128/IAI.00694-16

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  66 in total

Review 1.  Killer B lymphocytes: the evidence and the potential.

Authors:  Steven K Lundy
Journal:  Inflamm Res       Date:  2009-03-05       Impact factor: 4.575

2.  Virulent Coxiella burnetii pathotypes productively infect primary human alveolar macrophages.

Authors:  Joseph G Graham; Laura J MacDonald; S Kauser Hussain; Uma M Sharma; Richard C Kurten; Daniel E Voth
Journal:  Cell Microbiol       Date:  2013-01-14       Impact factor: 3.715

3.  Comparative virulence of intra- and interstrain lipopolysaccharide variants of Coxiella burnetii in the guinea pig model.

Authors:  A Moos; T Hackstadt
Journal:  Infect Immun       Date:  1987-05       Impact factor: 3.441

Review 4.  IL-1, IL-18, and IL-33 families of cytokines.

Authors:  William P Arend; Gaby Palmer; Cem Gabay
Journal:  Immunol Rev       Date:  2008-06       Impact factor: 12.988

5.  Lipopolysaccharide variation in Coxiella burnetti: intrastrain heterogeneity in structure and antigenicity.

Authors:  T Hackstadt; M G Peacock; P J Hitchcock; R L Cole
Journal:  Infect Immun       Date:  1985-05       Impact factor: 3.441

6.  Coxiella burnetii inhibits activation of host cell apoptosis through a mechanism that involves preventing cytochrome c release from mitochondria.

Authors:  Anja Lührmann; Craig R Roy
Journal:  Infect Immun       Date:  2007-08-20       Impact factor: 3.441

7.  Activated B cells express functional Fas ligand.

Authors:  M Hahne; T Renno; M Schroeter; M Irmler; L French; T Bornard; H R MacDonald; J Tschopp
Journal:  Eur J Immunol       Date:  1996-03       Impact factor: 5.532

8.  Nitric oxide produced by human B lymphocytes inhibits apoptosis and Epstein-Barr virus reactivation.

Authors:  J B Mannick; K Asano; K Izumi; E Kieff; J S Stamler
Journal:  Cell       Date:  1994-12-30       Impact factor: 41.582

9.  Caspase-1-induced pyroptosis is an innate immune effector mechanism against intracellular bacteria.

Authors:  Edward A Miao; Irina A Leaf; Piper M Treuting; Dat P Mao; Monica Dors; Anasuya Sarkar; Sarah E Warren; Mark D Wewers; Alan Aderem
Journal:  Nat Immunol       Date:  2010-11-07       Impact factor: 25.606

10.  Coxiella burnetii induces apoptosis during early stage infection via a caspase-independent pathway in human monocytic THP-1 cells.

Authors:  Yan Zhang; Guoquan Zhang; Laura R Hendrix; Vernon L Tesh; James E Samuel
Journal:  PLoS One       Date:  2012-01-27       Impact factor: 3.240

View more
  6 in total

1.  Coxiella burnetii Inhibits Neutrophil Apoptosis by Exploiting Survival Pathways and Antiapoptotic Protein Mcl-1.

Authors:  Rama Cherla; Yan Zhang; Lindsey Ledbetter; Guoquan Zhang
Journal:  Infect Immun       Date:  2018-03-22       Impact factor: 3.441

2.  To die or not to die: Programmed cell death responses and their interactions with Coxiella burnetii infection.

Authors:  Chelsea A Osbron; Alan G Goodman
Journal:  Mol Microbiol       Date:  2022-02-02       Impact factor: 3.979

3.  miR-424 promotes cardiac ischemia/reperfusion injury by direct targeting of CRISPLD2 and regulating cardiomyocyte pyroptosis.

Authors:  Yunpeng Lou; Shiying Wang; Jinlong Qu; Jinhao Zheng; Weiwei Jiang; Zhaofen Lin; Sheng Zhang
Journal:  Int J Clin Exp Pathol       Date:  2018-07-01

4.  The Feasibility of Using Coxiella burnetii Avirulent Nine Mile Phase II Viable Bacteria as a Live Attenuated Vaccine Against Q fever.

Authors:  Venkatesh Kumaresan; Shawkat Alam; Yan Zhang; Guoquan Zhang
Journal:  Front Immunol       Date:  2021-10-21       Impact factor: 7.561

Review 5.  Defying Death - How Coxiella burnetii Copes with Intentional Host Cell Suicide.

Authors:  Arne Cordsmeier; Nicole Wagner; Anja Lührmann; Christian Berens
Journal:  Yale J Biol Med       Date:  2019-12-20

6.  The anti-apoptotic Coxiella burnetii effector protein AnkG is a strain specific virulence factor.

Authors:  Walter Schäfer; Teresa Schmidt; Arne Cordsmeier; Vítor Borges; Paul A Beare; Julian Pechstein; Jan Schulze-Luehrmann; Jonas Holzinger; Nicole Wagner; Christian Berens; Carsten Heydel; João Paulo Gomes; Anja Lührmann
Journal:  Sci Rep       Date:  2020-09-21       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.